The invention relates to a nucleic acid polymerase capable of producing a non-DNA nucleotide polymer from a DNA nucleotide template, said polymerase comprising amino acid sequence having at least 36% identity to the amino acid sequence of SEQ ID NO:1, wherein said amino acid sequence is mutated relative to the amino acid sequence of SEQ ID NO:1 at one or more residues of the thumb region, said residues selected from: amino acids 651 to 679 (patch 10A); wherein said amino acid sequence is mutated relative to the amino acid sequence of SEQ ID NO:1 at residue E664. In one embodiment said polymerase comprises the mutations Y409G and E664K. In one embodiment said polymerase comprises amino acid sequence corresponding to SEQ ID NO:12. The invention also relates to A nucleic acid polymerase capable of reverse transcribing a HNA nucleotide polymer into a DNA nucleotide polymer, said polymerase comprising amino acid sequence having at least 36% identity to the amino acid sequence of sEQ ID NO:1, wherein said amino acid sequence is mutated relative to the amino acid sequence of SEQ ID NO:1 at residue I521.
1. A recombinant nucleic acid polymerase capable of producing DNA nucleic acid polymer from a non-DNA polymer template, said polymerase comprising an amino acid sequence having at least 85% identity to the amino acid sequence of SEQ ID NO:1;wherein said polymerase is mutated, relative to the amino acid sequence of SEQ ID NO:1, at residue I521.
2. The recombinant nucleic acid polymerase of claim 1 , wherein the non-DNA polymer template is a hexitol nucleic acid (HNA) polymer.
3. The recombinant nucleic acid polymerase of claim 1 , wherein said I521 mutation is selected from the group consisting of I521L, I521P, and I521H.
4. The recombinant nucleic acid polymerase of claim 1 , further comprising at least one mutation selected from group consisting of V93Q, D141A, E143A, and A485L relative to the amino acid sequence of SEQ ID NO:1.
5. The recombinant nucleic acid polymerase of claim 4 , wherein said polymerase comprises the mutation E664, and is capable of producing a HNA polymer from a DNA template.
6. The recombinant nucleic acid polymerase of claim 5 , wherein the HNA polymer is at least 50 nucleotides in length.
7. The recombinant nucleic acid polymerase of claim 1 , wherein said I521 mutation is selected from the group consisting of I521L, I521P, and I521H; and wherein said mutant polymerase further comprises mutations V93Q, D141A, E143A, and A485L relative to the amino acid sequence of SEQ ID NO:1.
8. The recombinant nucleic acid polymerase of claim 3 , further comprising at least one mutation selected from group consisting of V93Q, D141A, E143A, and A485L relative to the amino acid sequence of SEQ ID NO:1.
9. The recombinant nucleic acid polymerase of claim 1 , wherein said I521 mutation is I521L.
10. The recombinant nucleic acid polymerase of claim 1 , wherein said I521 mutation is I521L; and wherein said recombinant nucleic acid polymerase comprises mutations V93Q, D141A, E143A, E429G, A485L, and K726R relative to the amino acid sequence of SEQ ID NO:1.
11. The recombinant nucleic acid polymerase of claim 1 , wherein said polymerase further comprises a E664K mutation relative to the amino acid sequence of SEQ ID NO:1.
12. The recombinant nucleic acid polymerase of claim 5 , wherein said E664 mutation is E664K.